Big Pharma Spending Ratio on Canadian R&D Continues To Decline As IP Demands Increase |
| Print | |
|
Thursday June 21, 2012
|
|||||||||||
|
Now the same companies are lobbying relentlessly for a new round of patent reforms that they say will lead to further growth in research and development. However, a new report from government's Patented Medicines Prices Review Board shows that RxD spending to sales ratio continues a decade-long decline, hitting its lowest level since the 1987 reforms. Earlier this week, the chief Canadian negotiator on CETA appeared before the Standing Committee on International Trade and acknowledged the pressure from the EU to reform Canadian patent laws in support of RxD companies. He indicated that Canada has not responded to those demands. The time to respond has come: the RxD companies have failed to live up to their commitments for years and Canada will not offload billions in additional costs to taxpayers by implementing unnecessary patent reforms. Comments (6)
Bytowner
said:
|
|||||||||||
|
... Someone somewhere in one or more of those companies' leadership must be muttering the infamous declaration: "If we can't bankrupt the government with our product price tags, then this isn't a free country!" |
|
where R+D spending MIGHT be a function of how much of it gets leaked /or hacked. Quebec was attempting to get in on the-population-as -a-Guinness-pig train by buying up co's and moving it 'home' Now let's hear it for micro-bewery research... and it's support. packrat |
|
High anxiety A government that looked after Canadian interests would say, "When you live up to your commitments we'll consider your requests." That's too much to hope for with the current regime. |
|
An alternative model for producing pharmaceuticals What if the government created a crown corporation to produce pharmaceuticals, which charged less than private pharmaceutical companies for its products and focused all its (minimal) profit on R&D? Everyone hates how much profit pharmaceutical companies make so the government would definitely have public support for such a policy, alot like how everyone was against the big banks merging in the 90's. The fastest growing cost in health care is pharmaceutical prices. Why are we letting something essential to public health have its price determined by for profit corporations? If the government is serious about keeping our health care system sustainable they need to do something to lower the cost of pharmaceuticals and increase research and development. |
|
Great idea, Andrew! I thought of something like that for out-of-patent drugs that Big Pharma no longer want to produce, but are still required. |
We want to enhance competition and investment in this country, and this is why we adopted this policy back in 2008 for the AWS spectrum. Let me say that the price went down by an average of 11% since then, and we will continue this way with the 700 megahertz spectrum. We launched consultation with the industry to make sure that we enhance competition and provide better choice and better rates for our consumers.
Last week I wrote about the National Post seeking $150 licences for posting short excerpts online. It appears that the paper has now dropped the system.
Mar.12/13Comments (1)
Subscribe to this comment's feed